Implications for practice: phase II/III trial of carboplatin and irinotecan for elderly patients with extensive-stage small-cell lung cancer in Japan
J Thorac Dis
.
2024 Sep 30;16(9):6342-6346.
doi: 10.21037/jtd-24-279.
Epub 2024 Sep 23.
Authors
Shipra Maheshwari
1
,
Ryan D Gentzler
1
Affiliation
1
Division of Hematology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA.
PMID:
39444913
PMCID:
PMC11494565
DOI:
10.21037/jtd-24-279
No abstract available
Keywords:
Small-cell lung cancer (SCLC); carboplatin; etoposide; immunotherapy; irinotecan.
Publication types
Editorial
Comment